NCT03602625 (RFPTB) is a clinical trial in Risk Factors, sponsored by Children's Hospital of Fudan University.

Who is sponsoring NCT03602625?

NCT03602625 is sponsored by Children's Hospital of Fudan University.

What condition does NCT03602625 study?

NCT03602625 studies Risk Factors.

Is NCT03602625 still recruiting?

NCT03602625 is currently completed. Last updated 26 March 2019.

Last reviewed 2019-03-26 · How we verify

NCT03602625: RFPTB

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Risk Factors of Preterm Birth Born in Hospital：a Prospective Multicenter Case-control Study

Completed Last updated 26 March 2019

What this trial tests

trial in Risk Factors in 6,000 participants. Completed in 31 December 2018.

Timeline

1 January 2018

Primary endpoint
31 December 2018

31 December 2018

Quick facts

Lead sponsor	Children's Hospital of Fudan University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	6,000
Start date	1 January 2018
Primary completion	31 December 2018
Estimated completion	31 December 2018
Sites	15 locations across China

Conditions studied

Risk Factors — all drugs for Risk Factors →

Sponsor

Children's Hospital of Fudan University

Who can join

Under 28 Days, any sex, with Risk Factors. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to explore the perinatal risk factors of preterm birth in China.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Risk Factors

Currently open trials in the same condition.

NCT06340178 — CT-guided Lung Biopsy Risk Optimization Method · NA · recruiting
NCT07233447 — Prevalence of H. Pylori in Stomach Cancers in the West Indies · recruiting
NCT06441240 — Evaluation of Recurrence Risk Factors in Locally Advanced Breast Cancer Patients Underwent Neoadjuvant Chemotherapy. · recruiting
NCT05916287 — FAMILY INHERITANCE, GENE-GENE AND GENE-ENVIRONMENT INTERACTIONS IN THE FIELD OF CARDIOVASCULAR AND RENAL DISEASES. Fifth · NA · recruiting
NCT06159699 — Telecommunication Technology-based Online Survey · recruiting

Other Children's Hospital of Fudan University trials

Trials by the same sponsor.

NCT04955821 — Early Identification of Pathogens in Children With Respiratory Tract Infection by Mechanical Ventilation Using mNGS · not yet recruiting
NCT05862688 — A Cohort Study on Anti-microbial Stewardship in PICU · not yet recruiting
NCT05595239 — Blood Purification in Septic Children · NA · not yet recruiting
NCT07325903 — Research of Integrated Traditional Chinese and Western Medicine on Precocious Puberty · EARLY_PHASE1 · not yet recruiting
NCT07141615 — Clinical Observation of Qingwei Huazhuo Decoction (Product: Jinsaiyu) in Improving Children With Precocious Puberty of P · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03602625 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Children's Hospital of Fudan University
Last refreshed: 26 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03602625.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing